Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Translational Medicine Summit

Michael Schnekenburger's Biography



Michael Schnekenburger, Team Leader, Laboratoire de Biologie Moléculaire et Cellulaire du Cancer

Sorry, There is currently no biography for this presenter.

Michael Schnekenburger Image

Translating Epigenetic Alterations in Leukemia into Biomarkers of the Disease and for Target Therapies with DNA Demethylating Drugs

Friday, 7 June 2013 at 11:00

Add to Calendar ▼2013-06-07 11:00:002013-06-07 12:00:00Europe/LondonTranslating Epigenetic Alterations in Leukemia into Biomarkers of the Disease and for Target Therapies with DNA Demethylating DrugsTranslational Medicine Summit in HamburgHamburgSELECTBIOenquiries@selectbiosciences.com

Aberrant DNA methylation patterns are a common hallmark of tumor cells. We will discuss the translational potential of these epimutations as cancer biomarkers and possible therapeutic strategies related to DNA demethylation.


Add to Calendar ▼2013-06-06 00:00:002013-06-07 00:00:00Europe/LondonTranslational Medicine SummitTranslational Medicine Summit in HamburgHamburgSELECTBIOenquiries@selectbiosciences.com